HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,430.00
-5.00 (-0.11%)
At close: Feb 13, 2026
Market Cap132.90B -5.0%
Revenue (ttm)129.68B +16.0%
Net Income-3.14B
EPS-104.67
Shares Out30.00M
PE Ratio10.68
Forward PEn/a
Dividend35.00 (0.79%)
Ex-Dividend DateApr 2, 2026
Volume101,748
Average Volume94,528
Open4,420.00
Previous Close4,435.00
Day's Range4,390.00 - 4,470.00
52-Week Range3,825.00 - 5,420.00
Beta0.83
RSI59.83
Earnings DateFeb 4, 2026

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 341
Stock Exchange KOSDAQ
Ticker Symbol 052260
Full Company Profile

Financial Performance

In 2024, HYUNDAI BIOLAND's revenue was 119.52 billion, an increase of 23.57% compared to the previous year's 96.72 billion. Earnings were 5.70 billion, a decrease of -29.21%.

Financial Statements